ArticleJCO oncology practice2020
Considerations for Managing Patients With Hematologic Malignancy During the COVID-19 Pandemic: The Seattle Strategy.
Article in JCO oncology practice, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
18 citing papers in PubMed.
- Article
- Management of SARS-CoV-2 infection is a major challenge in patients with lymphoid malignancies: Warrants a clear therapeutic strategy.World journal of virology · 2022Article
- Reduced bendamustine for elderly patients with follicular lymphoma.Annals of hematology · 2022Article
- Treatment Approaches for Managing Patients with Hematological Malignancies in the Time of COVID-19 Pandemic.Turkish journal of medical sciences · 2021Review
- Characteristics and outcomes of five patients with COVID-19 and hematological malignancies.Clinical case reports · 2021Article
- The Impact of COVID-19 on Cancer Care in the Post Pandemic World: Five Major Lessons Learnt from Challenges and Countermeasures of Major Asian Cancer Centres.Asian Pacific journal of cancer prevention : APJCP · 2021Article
- Indian Expert Opinion on Cancer Care during COVID-19 Pandemic.South Asian journal of cancer · 2021Article
- COVID-19 infection in patients with acute leukemia; Istanbul experience.American journal of blood research · 2021Article
- Favourable outcomes for young lymphoma patients but age-old problems persist.EClinicalMedicine · 2020Article
- [Increase in the severity of acute malignant hemopathies during the COVID-19 pandemia].Medicina clinica · 2020Article
- Increase in the severity of acute malignant hemopathies during the COVID-19 pandemia.Medicina clinica (English ed.) · 2020Article
- Developing a holistic contingency plan: Challenges and dilemmas for cancer patients during the COVID-19.Cancer medicine · 2020Review
- Article
- COVID-19: The Impact in Oncology Care.SN comprehensive clinical medicine · 2020Review
- SARS-CoV-2 testing for asymptomatic adult cancer patients before initiating systemic treatments: a systematic review.Ecancermedicalscience · 2020Review
- Cancer or COVID-19? A Review of Guidelines for Safe Cancer Care in the Wake of the Pandemic.SN comprehensive clinical medicine · 2020Review
- COVID-19 in hematology: data from a hematologic and transplant unit.Hematology, transfusion and cell therapyArticle
- Saudi Lymphoma Group's Clinical Practice Guidelines for Diagnosis, Management and Follow-up of Patients with Various Types of Lymphoma during the Coronavirus Disease 2019 Pandemic.Saudi journal of medicine & medical sciencesArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
16 authors.
Funding
Abstract
In January 2020, the first documented patient in the United States infected with severe acute respiratory syndrome coronavirus 2 was diagnosed in Washington State. Since that time, community spread of coronavirus disease 2019 (COVID-19) in the state has changed the practice of oncologic care at our comprehensive cancer center in Seattle. At the Seattle Cancer Care Alliance, the primary oncology clinic for the University of Washington/Fred Hutchinson Cancer Consortium, our specialists who manage adult patients with hematologic malignancies have rapidly adjusted clinical practices to mitigate the potential risks of COVID-19 to our patients. We suggest that our general management decisions and modifications in Seattle are broadly applicable to patients with hematologic malignancies. Despite a rapidly changing environment that necessitates opinion-based care, we provide recommendations that are based on best available data from clinical trials and collective knowledge of disease states.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.